Overview: MCV/MCH Ratio TestIntroduction: The MCV/MCH Ratio Test calculates MCV/MCH ratio to diagnose anemia types, helping identify causes of fatigue or weakness based on red blood cell size and hemoglobin content. Affecting 1 in 10 people with anemia, this ratio poses diagnostic challenges due to diverse etiologies. Following 2023 American Society of Hematology (ASH) guidelines, it uses automated hematology analyzer for high accuracy, supporting hematology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in hematology.Other Names: Red Cell Index Ratio Test, Anemia Profile Assay.FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic reliability.Historical Milestone: Red cell index testing began in the 1950s with research by Wintrobe, who developed MCV and MCH. Automated analyzer advancements in the 1990s by Beckman Coulter improved detection, surpassing earlier manual counts.Purpose: Calculates MCV/MCH ratio to diagnose anemia types, guides iron or vitamin therapy, and evaluates patients with fatigue, aiming to resolve symptoms.Test Parameters: MCV/MCH ratioPretest Condition: No special preparation required. Collect whole blood. Report history of anemia.Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in EDTA tube. Transport in a biohazard container.Sample Stability at Room Temperature: 24 hoursSample Stability at Refrigeration: 1 weekSample Stability at Frozen: 1 monthMedical History: Document fatigue or weakness. Include current medications or diet.Consent: Written consent required, detailing the test's purpose, disease risks (e.g., organ damage), and sample collection risks.Procedural Considerations: Uses automated hematology analyzer to measure ratio, requiring labs with analyzers. Results available in 1-2 days. Performed in labs with strict handling.Factors Affecting Result Accuracy: Sample clotting or contamination can affect results. Medications may alter counts, requiring correlation.Clinical Significance: Abnormal ratio identifies anemia type, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Normal levels may require iron studies.Specialist Consultation: Consult a hematologist for interpretation.Additional Supporting Tests: Iron panel, ferritin, or peripheral smear to confirm diagnosis.Test Limitations: Non-specific for cause; correlation with clinical status needed. False results possible with mixed anemia.References: ASH Guidelines, 2023; Blood, Wintrobe MM, 2022.